Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable Dialysis
Clinical trial NCT02278341 · COMPLETED
Trial details
- NCT number
- NCT02278341
- Sponsor
- Astellas Pharma Europe B.V.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-21
- Primary completion
- 2017-06-08
- Enrollment
- 838
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.